July 2026
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the effects of oral semaglutide on cardiovascular outcomes in patients with type 2 diabetes, finding a 14% reduction in major adverse cardiovascular events compared to placebo.
Outcomes
Adverse events incidenceAll-cause mortalityBMI+7 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the effect of oral semaglutide on heart failure events in patients with type 2 diabetes, finding a reduced risk of composite heart failure outcomes compared to placebo.
Outcomes
Composite cardiovascular events (CV death, MI, stroke, HF hospitalization)Hyperglycemia eventsHypoglycemia events+1 more
Added to Dediabetes Jul 12, 2026RCTs
Orforglipron treatment led to significant reductions in cardiovascular risk markers among participants with type 2 diabetes and obesity.
Interventions
Orforglipron
Outcomes
Apolipoprotein B changeApolipoprotein C3 changeC-reactive protein+5 more
Added to Dediabetes Jul 12, 2026Randomized Controlled Trial
This 12-week trial tested oxygen-enriched ELO water as an add-on therapy in adults with type 2 diabetes. HbA1c fell modestly in the ELO group, especially by week 6 compared with placebo, but fasting glucose and body weight did not clearly improve.
Interventions
Oxygen-enriched water
Outcomes
Adverse events incidenceBody weightFasting blood sugar (FBS)+2 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the impact of peer-created digital storytelling videos on psychological outcomes in individuals with Type 1 diabetes. Significant improvements in diabetes distress, burnout, and depressive symptoms were observed in the intervention group.
Interventions
Digital storytelling behavioral interventionUsual care
Outcomes
Depression scoreDiabetes burnout scoresDiabetes distress scores+1 more
Added to Dediabetes Jul 12, 2026Cluster Randomized Controlled Trial
This cluster-randomized trial tested a community-based peer-support lifestyle program in 1,007 high-risk Indian adults. The program improved diet, reduced alcohol use, and enhanced physical functioning, but the 14.9% vs 17.1% reduction in diabetes incidence was not statistically significant.
Interventions
Peer-support lifestyle program
Outcomes
Alcohol useFruit and vegetable intakeIndian Diabetes Risk Score+2 more
Added to Dediabetes Jul 12, 2026RCTs
This study investigated the impact of peripheral electrical stimulation on glucose control in type 2 diabetes patients, showing significant improvements in nocturnal glucose control.
Interventions
Peripheral electrical stimulation (PES)
Outcomes
Adverse events incidenceBlood glucoseInsulin+3 more
Added to Dediabetes Jul 12, 2026RCTs
This study evaluated the effectiveness of pharmacotherapy for achieving diabetes remission. It found that both intervention and control groups had patients in remission, with notable weight loss in the intervention group.
Interventions
Liraglutide, Dapagliflozin, and MetforminMetformin + glimepiride
Outcomes
BMIBody fat massBody fat percentage reduction+4 more
Added to Dediabetes Jul 12, 2026Randomised Controlled Trial
This study tested a lifestyle programme for new mothers who had gestational diabetes, to help prevent later type 2 diabetes. Women in the programme maintained their weight while those receiving usual care gained weight over 12 months. However, most women did not fully participate in the programme, and there were no clear improvements in waist size or blood sugar.
Interventions
Lifestyle intervention for prediabetes
Outcomes
Body weightDepression scoreFasting blood sugar (FBS)+1 more
Added to Dediabetes Jul 12, 2026RCTs
This study investigated how pre-pregnancy BMI influences the effect of prebiotic supplementation on gestational diabetes mellitus (GDM) rates.
Interventions
Prebiotic supplementation
Outcomes
Gestational diabetes mellitus incidence